JOHN. K. CINI, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sonnet BioTherapeutics Holdings, Inc.

Filing Date Source Excerpt
2022-08-25 John. K. Cini, Ph.D. 224,067 shares (6) **

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22